IONS (Ionis Pharmaceuticals, Inc.) Tingkat bathi miturut bathi reged

Lambang korporat lan logo Ionis Pharmaceuticals, Inc. (IONS)

Ionis Pharmaceuticals (IONS) generates revenue through royalties from RNA therapy partnerships. Diversifying its drug portfolio across various pathologies mitigates financial risks, while the growth of its user base depends on FDA approvals. Production margins demonstrate cost efficiency, where the 95.40 level serves as the current metric, confirming the company's ability to maintain profits amid fluctuations in cost of goods sold.

Tingkat bathi miturut bathi reged: Ionis Pharmaceuticals (IONS) kanggo 04.07.2022 - 20.11.2026

Rincian metrik keuangan lan pasar ionispharma.com (IONS)

- nilai pasar lan prakiraan target analis:
- indikator valuasi pasar bisnis:
Pambiji fundamental:IONS, Ionis
Barang unggulan Ionis Pharmaceuticals

To build a portfolio of high-quality assets, I evaluate cost management efficiency via the gross margin. This ratio determines the profit share after deducting direct production costs, measuring the business's fundamental ability to generate cash flow. For Ionis Pharmaceuticals (IONS), its status as an RNA therapy innovator allows it to maintain high product pricing due to the uniqueness of its platforms. Analyzing sales margins helps identify overvaluation risks or buy signals in a timely manner.

Pesaing langsung

Tingkat bathi miturut bathi reged Tempus AI Inc|QGEN (Qiagen NV) - Margin reged|Repligen Inc. - Tingkat bathi adhedhasar bathi reged|Margin reged RNA|CRSP - Margin bathi reged|GeneDx - Tingkat bathi miturut bathi reged|Tingkat bathi reged RARE|Beam Tx - Margin reged|SRPT - Margin reged|TWST (Twist Bio) - Tingkat bathi miturut bathi reged|Rentabilitas dodolan reged TXG|Tingkat bathi miturut bathi reged NTLA|Stoke Therapeutics Inc (STOK) - Rentabilitas dodolan miturut bathi reged|Margin reged BLFS|Rentabilitas reged WVE (Wave Life Sciences Corp)|Rentabilitas reged Maze Therapeutics MAZE|Tingkat bathi reged SION|PRME - Rentabilitas reged|Rentabilitas dodolan miturut bathi reged Taysha TSHA|QURE: Margin reged|Tingkat bathi miturut bathi reged MeiraGTx PLC|RGNX (REGENXBIO Inc) - Margin reged|solidbio.com (SLDB) - Rentabilitas dodolan miturut bathi reged|Rentabilitas reged Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Rentabilitas dodolan reged|Benitec Biopharma - Tingkat bathi miturut bathi reged|DSGN: Rentabilitas dodolan reged|RCKT: Tingkat bathi miturut bathi reged|FDMT - Margin reged|LXEO: Margin reged|Korro Bio Inc. - Tingkat bathi reged|EDIT (editasmedicine.com) - Margin reged|Rentabilitas reged SLN|Rentabilitas reged ProQR Therapeutics NV (PRQR)|Codexis - Rentabilitas dodolan reged|Rentabilitas reged Sangamo SGMO|NAUT: Rentabilitas dodolan reged|MGX: Tingkat bathi miturut bathi reged|Margin bathi reged Precision BioSciences|GBIO (generationbio.com) - Tingkat bathi miturut bathi reged|Margin bathi reged boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Margin reged|Rentabilitas dodolan reged IMNN (Imunon, Inc.)|Margin reged PHIO|MBIO - Margin bathi reged|Margin reged RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Margin bathi reged|Applied DNA - Margin reged|Margin bathi reged Bluebird Bio|ImmunoPrecise (IPA) - Rentabilitas reged|Tingkat bathi adhedhasar bathi reged OMGA (Omega)|Rentabilitas reged Singular Genomics Systems|Margin bathi reged regulusrx.com RGLS|Rentabilitas reged Syros Pharmaceuticals Inc. (SYRS)|Rentabilitas dodolan miturut bathi reged Codex DNA|Rentabilitas reged TRACON TCON|Unity Biotechnology, Inc - Rentabilitas reged